BBH (BBH) Stock Price & Analysis
BBH (BBH) rose 0.94% to USD 187.49 as of June 10, 2026 at 13:19 UTC, according to Nexqual real-time market data.
BBH last closed at USD 185.74; the session ranged USD 185.31–188.02 on volume of 3,756 shares. Market capitalization is —, with a 52-week range of USD 150.18–202.91 (NGM). Source: Nexqual, June 10, 2026 at 13:19 UTC.
Key Statistics (as of June 10, 2026 at 13:19 UTC)
| Price | USD 187.49 |
|---|---|
| Change | ▲ 0.94% (up) |
| Previous Close | USD 185.74 |
| Open | USD 188.02 |
| Day Range | USD 185.31 – 188.02 |
| 52-Week Range | USD 150.18 – 202.91 |
| Volume | 3,756 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (BBH)
Nexqual's technical model rates BBH "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 13:19 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 51.07 (neutral) |
| vs SMA50 | Above (USD 186.8) |
| MACD | 0.25 (positive) |
Financial Health Score (BBH)
Nexqual rates BBH's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 13:19 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PPH | VanEck Pharmaceutical ETF | USD 105.89 | ▲ 0.13% |
| HHH | Howard Hughes Holdings Inc. | USD 67.68 | ▲ 3.92% |
| RTH | VanEck Retail ETF | USD 258.18 | ▲ 0.72% |
| PBE | Invesco Biotechnology & Genome | USD 84.25 | ▲ 0.92% |
| FBT | First Trust Amex Biotech Index | USD 226.09 | ▲ 1.5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:19 UTC. This page is informational and not investment advice.